Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advitech, a health sciences and technology company, has signed a distribution agreement with PL Thomas & Co, a provider of active ingredients for nutraceutical, cosmeceutical and functional foods industries, for the sale and marketing of its ingredient XP-828L for the US market.
Subscribe to our email newsletter
Advitech and PL Thomas (PLT) have concluded a non-exclusive distribution agreement with a yearly commitment for Advitech’s XP-828L ingredient, a patent-pending composition consisting of growth factors, especially TGF- B2, capable to maintain healthy cytokines levels and to support inflammatory process.
Other products of the Advitech portfolio, as well as several new innovations, could be added in the Advitech-PLT agreement upon further discussions, the two companies said.
Luc Clouatre, vice-president of business development, sales and marketing at Advitech, said: “The agreement with PLT is significant as it is an important player in several segments of the American market targeted by Advitech. PL Thomas has strong market visibility and existing business with many of the companies in the food and dietary supplements industry.”